AEHR vs ACLS

Axcelis Technologies, Inc.

(ACLS) offers the better valuation at 45. 0x trailing P/E (43. 5x forward), making it the more compelling value choice. Analysts rate Axcelis Technologies, Inc. (ACLS) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +42.

0%, compared to +324. 6% for Axcelis Technologies, Inc. (ACLS). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus ACLS's +1506%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Axcelis Technologies, Inc.

(ACLS) is the lower-risk stock at 2. 00β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 139% more volatile than ACLS relative to the S&P 500. On balance sheet safety, Axcelis Technologies, Inc. (ACLS) carries a lower debt/equity ratio of 4% versus 9% for Aehr Test Systems — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: Aehr Test Systems grew EPS 0.

0% year-over-year, compared to -38. 2% for Axcelis Technologies, Inc.. Over a 3-year CAGR, AEHR leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Axcelis Technologies, Inc.

(ACLS) is the more profitable company, earning 14. 3% net margin versus -6. 6% for Aehr Test Systems — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus -7. 3% for AEHR. At the gross margin level — before operating expenses — ACLS leads at 44. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ACLS: -25.

1% to $128. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Axcelis Technologies, Inc.

(ACLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1506% 10Y return). Aehr Test Systems (AEHR) carries a higher beta of 4. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLS: +1506%, AEHR: +70. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.